Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(21 sites)
United States
Stern Center for Cancer Clinical Trials and Research, Orange, California UCHealth Cancer Care - Anschutz Medical Campus, Aurora, Colorado Horizon Oncology Research, LLC., Layfayette, Indiana Mass General Hospital, Boston, Massachusetts Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey